2012
DOI: 10.1089/ten.tea.2011.0647
|View full text |Cite
|
Sign up to set email alerts
|

Enhanced Cartilage Formation via Three-Dimensional Cell Engineering of Human Adipose-Derived Stem Cells

Abstract: Autologous chondrocyte implantation is an effective treatment for damaged articular cartilage. However, this method involves surgical procedures that may cause further cartilage degeneration, and in vitro expansion of chondrocytes can result in dedifferentiation. Adipose-derived stem cells (ADSCs) may be an alternative autologous cell source for cartilage regeneration. In this study, we developed an effective method for large-scale in vitro chondrogenic differentiation, which is the procedure that would be req… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
120
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 136 publications
(121 citation statements)
references
References 25 publications
1
120
0
Order By: Relevance
“…Neocartilage formation with integration with the surrounding host cartilage and bone has also been found in a larger model system using pig ASCs and full thickness articular defects [213], a model system that could provide important information on the way to the use of ASCs in the clinic. As a precursor to clinical application, successful cartilage formation in vivo has recently been reported using large-scale in vitro differentiation methods for the production of multiple spheroids suitable for implantation from human ASCS [214]. Finally, chondrogenic differentiation by ASCs in vivo cannot only be induced through their preinduction with TGF 1, but induced in vivo by using the scaffold itself.…”
Section: In Vivo Cartilagementioning
confidence: 99%
“…Neocartilage formation with integration with the surrounding host cartilage and bone has also been found in a larger model system using pig ASCs and full thickness articular defects [213], a model system that could provide important information on the way to the use of ASCs in the clinic. As a precursor to clinical application, successful cartilage formation in vivo has recently been reported using large-scale in vitro differentiation methods for the production of multiple spheroids suitable for implantation from human ASCS [214]. Finally, chondrogenic differentiation by ASCs in vivo cannot only be induced through their preinduction with TGF 1, but induced in vivo by using the scaffold itself.…”
Section: In Vivo Cartilagementioning
confidence: 99%
“…Thus, much research is currently underway to improve cartilage tissue-engineering techniques. 10 Chondrocytes derived from natural sources or from MSCs differentiating toward chondrocytes are commonly used as a cell source in cartilage tissue engineering; however, there are unmet challenges in expanding and maintaining chondrocytes (e.g., the composition of the construct and the regulation of culture conditions need careful monitoring). 13,14,50,56,57 In addition, chondrogenic growth factors play a key role in chondrocyte differentiation and cartilage generation.…”
Section: Cartilage Tissue Engineeringmentioning
confidence: 99%
“…These techniques combine biocompatible scaffolds (natural or synthetic), appropriate cell types, and cell signaling molecules to create a tissue that mimics the functional native tissue. 10 Scaffolds are selected based on their ability to promote adhesion and proliferation of the desired cell types, although scaffold-free methods have also been reported in the literature. 11,12 As a cell source, either chondrocytes harvested from cartilage or mesenchymal stem cells (MSCs) differentiating toward chondrocytes are used.…”
mentioning
confidence: 99%
“…For example, engineered cartilage aims to provide a long-term relief to patients with osteoarthritis or to individuals with acute sports injuries [3], whereas engineered bone can provide a cure for large bone defects [4]. Cartilage tissue engineering uses chondrocytes or mesenchymal stem cells as the cell source, hydrogel or fibrin based scaffolds and biomimetic or growth factor delivery based growth conditions to produce a native like functional cartilage engineered tissue [5][6][7][8]. The growth conditions such as the cell density, the mechanical properties of scaffolds, the oxygen concentration and the growth factor strength are varied to test the effectiveness of engineered tissue for its target biochemical and mechanical properties [5,9,10].…”
Section: Introductionmentioning
confidence: 99%
“…Cartilage tissue engineering uses chondrocytes or mesenchymal stem cells as the cell source, hydrogel or fibrin based scaffolds and biomimetic or growth factor delivery based growth conditions to produce a native like functional cartilage engineered tissue [5][6][7][8]. The growth conditions such as the cell density, the mechanical properties of scaffolds, the oxygen concentration and the growth factor strength are varied to test the effectiveness of engineered tissue for its target biochemical and mechanical properties [5,9,10]. Bone tissue engineering uses similar but bone-specific strategies, such as bone marrow derived mesenchymal stem cells (MSCs), suitable scaffolds and growth conditions to stimulate osteogenic differentiation of cells, to generate engineered bone with target biochemical and mechanical properties like a native bone [11][12][13][14][15][16].…”
Section: Introductionmentioning
confidence: 99%